(Q54168789)

25 May 2018

title

c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy. (English)

1 reference

25 May 2018

author name string

L M Vargas-Roig

1

1 reference

25 May 2018

F E Gago

2

1 reference

25 May 2018

O Tello

3

1 reference

25 May 2018

M T Martin de Civetta

4

1 reference

25 May 2018

D R Ciocca

5

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 April 1999

1 reference

25 May 2018

International Journal of Cancer

published in

1 reference

25 May 2018

volume

84

1 reference

25 May 2018

issue

2

1 reference

25 May 2018

page(s)

129-134

1 reference

25 May 2018

Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

p53 protein overexpression and chemosensitivity in breast cancer. Institut Gustave-Roussy Breast Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Preoperative chemotherapy in operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Changes in biological markers after primary chemotherapy for breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Ondansetron for intractable vertigo complicating acute brainstem disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Clinical therapy and HER-2 oncogene amplification in breast cancer: chemo- vs radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990420%2984%3A2%3C129%3A%3AAID-IJC6%3E3.0.CO%3B2-4

10.1002/(SICI)1097-0215(19990420)84:2<129::AID-IJC6>3.0.CO;2-4

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

PubMed ID

10096243

1 reference

25 May 2018